Aquaretic treatment in polycystic kidney disease
- PMID: 23121376
- DOI: 10.1056/NEJMe1211857
Aquaretic treatment in polycystic kidney disease
Comment on
-
Tolvaptan in patients with autosomal dominant polycystic kidney disease.N Engl J Med. 2012 Dec 20;367(25):2407-18. doi: 10.1056/NEJMoa1205511. Epub 2012 Nov 3. N Engl J Med. 2012. PMID: 23121377 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources